# ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

> **NCT00981578** · NA · TERMINATED · sponsor: **InSightec** · enrollment: 37 (actual)

## Conditions studied

- Bone Metastases

## Interventions

- **DEVICE:** ExAblate 2100

## Key facts

- **NCT ID:** NCT00981578
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2016-11-14
- **Final completion:** 2016-11-14
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Terminated due to low enrollment.
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981578, "ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00981578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*